Page last updated: 2024-10-24

carbamazepine and Acquired Nephrogenic Diabetes Insipidus

carbamazepine has been researched along with Acquired Nephrogenic Diabetes Insipidus in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berendes, K1

Other Studies

1 other study available for carbamazepine and Acquired Nephrogenic Diabetes Insipidus

ArticleYear
[Hypo- and hypernatremia].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:21

    Topics: Anticonvulsants; Antimanic Agents; Carbamazepine; Diabetes Insipidus, Nephrogenic; Humans; Hypernatr

2011